Literature DB >> 33020164

Azole and Amphotericin B MIC Values against Aspergillus fumigatus: High Agreement between Spectrophotometric and Visual Readings Using the EUCAST EDef 9.3.2 Procedure.

Pilar Escribano1,2, Jesús Guinea3,2,4, Julia Serrano-Lobo1,2, Ana Gómez1,2, Waldo Sánchez-Yebra5, Miguel Fajardo6, Belén Lorenzo7, Ferrán Sánchez-Reus8, Inmaculada Vidal9, Marina Fernández-Torres10, Isabel Sánchez-Romero11, Carlos Ruiz de Alegría-Puig12, José Luis Del Pozo13, Patricia Muñoz1,2,4,14.   

Abstract

The EUCAST EDef 9.3.2 procedure recommends visual readings of azole and amphotericin B MICs against Aspergillus spp. Visual determination of MICs may be challenging. In this work, we aim to obtain and compare visual and spectrophotometric MIC readings of azoles and amphotericin B against Aspergillus fumigatus sensu lato isolates. A total of 847 A. fumigatus sensu lato isolates (A. fumigatus sensu stricto [n = 828] and cryptic species [n = 19]) were tested against amphotericin B, itraconazole, voriconazole, posaconazole, and isavuconazole using the EUCAST EDef 9.3.2 procedure. Isolates were classified as susceptible or resistant/non-wild type according to the 2020 updated breakpoints. The area of technical uncertainty for the azoles was defined in the updated breakpoints. Visual and spectrophotometric (fungal growth reduction of >95% compared to the control, read at 540 nm) MICs were compared. Essential (±1 2-fold dilution) and categorical agreements were calculated. Overall, high essential (97.1%) and categorical (99.6%) agreements were found. We obtained 100% categorical agreements for amphotericin B, itraconazole, and posaconazole, and consequently, no errors were found. Categorical agreements were 98.7 and 99.3% for voriconazole and isavuconazole, respectively. Most of the misclassifications for voriconazole and isavuconazole were found to be associated with MIC results falling either in the area of technical uncertainty or within one 2-fold dilution above the breakpoint. The resistance rate was slightly lower when the MICs were obtained by spectrophotometric readings. However, all relevant cyp51A mutants were correctly classified as resistant. Spectrophotometric determination of azole and amphotericin B MICs against A. fumigatus sensu lato isolates may be a convenient alternative to visual endpoint readings.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Aspergillus fumigatuszzm321990; EUCAST; amphotericin B; azoles; spectrophotometric

Year:  2020        PMID: 33020164      PMCID: PMC7927860          DOI: 10.1128/AAC.01693-20

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

Review 1.  Evolution of antifungal-drug resistance: mechanisms and pathogen fitness.

Authors:  James B Anderson
Journal:  Nat Rev Microbiol       Date:  2005-07       Impact factor: 60.633

2.  EUCAST Technical Note on the method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for conidia-forming moulds.

Authors: 
Journal:  Clin Microbiol Infect       Date:  2008-10       Impact factor: 8.067

Review 3.  The role of azoles in the management of azole-resistant aspergillosis: from the bench to the bedside.

Authors:  Seyedmojtaba Seyedmousavi; Johan W Mouton; Willem J G Melchers; Roger J M Brüggemann; Paul E Verweij
Journal:  Drug Resist Updat       Date:  2014-07-05       Impact factor: 18.500

4.  Molecular Identification and Susceptibility Testing of Molds Isolated in a Prospective Surveillance of Triazole Resistance in Spain (FILPOP2 Study).

Authors:  Ana Alastruey-Izquierdo; Laura Alcazar-Fuoli; Olga Rivero-Menéndez; Josefina Ayats; Carmen Castro; Julio García-Rodríguez; Lidia Goterris-Bonet; Elisa Ibáñez-Martínez; María José Linares-Sicilia; M Teresa Martin-Gomez; Estrella Martín-Mazuelos; Teresa Pelaez; Javier Peman; Antonio Rezusta; Susana Rojo; Rocio Tejero; Diego Vicente Anza; Jesús Viñuelas; Maria Soledad Zapico; Manuel Cuenca-Estrella
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

Review 5.  Triazole resistance in Aspergillus fumigatus: recent insights and challenges for patient management.

Authors:  P P A Lestrade; J F Meis; W J G Melchers; P E Verweij
Journal:  Clin Microbiol Infect       Date:  2018-12-21       Impact factor: 8.067

6.  Rapid antifungal susceptibility determination for yeast isolates by use of Etest performed directly on blood samples from patients with fungemia.

Authors:  Jesús Guinea; Sandra Recio; Pilar Escribano; Marta Torres-Narbona; Teresa Peláez; Carlos Sánchez-Carrillo; Marta Rodríguez-Créixems; Emilio Bouza
Journal:  J Clin Microbiol       Date:  2010-04-14       Impact factor: 5.948

7.  Comparison of spectrophotometric and visual readings of NCCLS method and evaluation of a colorimetric method based on reduction of a soluble tetrazolium salt, 2,3-bis [2-methoxy-4-nitro-5-[(sulfenylamino) carbonyl]-2H-tetrazolium-hydroxide], for antifungal susceptibility testing of Aspergillus species.

Authors:  J Meletiadis; J W Mouton; J F Meis; B A Bouman; P J Donnelly; P E Verweij
Journal:  J Clin Microbiol       Date:  2001-12       Impact factor: 5.948

Review 8.  Aspergillus species intrinsically resistant to antifungal agents.

Authors:  Jan W M Van Der Linden; Adilia Warris; Paul E Verweij
Journal:  Med Mycol       Date:  2010-07-22       Impact factor: 4.076

9.  Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

Authors:  A J Ullmann; J M Aguado; S Arikan-Akdagli; D W Denning; A H Groll; K Lagrou; C Lass-Flörl; R E Lewis; P Munoz; P E Verweij; A Warris; F Ader; M Akova; M C Arendrup; R A Barnes; C Beigelman-Aubry; S Blot; E Bouza; R J M Brüggemann; D Buchheidt; J Cadranel; E Castagnola; A Chakrabarti; M Cuenca-Estrella; G Dimopoulos; J Fortun; J-P Gangneux; J Garbino; W J Heinz; R Herbrecht; C P Heussel; C C Kibbler; N Klimko; B J Kullberg; C Lange; T Lehrnbecher; J Löffler; O Lortholary; J Maertens; O Marchetti; J F Meis; L Pagano; P Ribaud; M Richardson; E Roilides; M Ruhnke; M Sanguinetti; D C Sheppard; J Sinkó; A Skiada; M J G T Vehreschild; C Viscoli; O A Cornely
Journal:  Clin Microbiol Infect       Date:  2018-03-12       Impact factor: 8.067

10.  Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus.

Authors:  J W M van der Linden; M C Arendrup; A Warris; K Lagrou; H Pelloux; P M Hauser; E Chryssanthou; E Mellado; S E Kidd; A M Tortorano; E Dannaoui; P Gaustad; J W Baddley; A Uekötter; C Lass-Flörl; N Klimko; C B Moore; D W Denning; A C Pasqualotto; C Kibbler; S Arikan-Akdagli; D Andes; J Meletiadis; L Naumiuk; M Nucci; W J G Melchers; P E Verweij
Journal:  Emerg Infect Dis       Date:  2015-06       Impact factor: 6.883

View more
  5 in total

1.  Calcimycin Inhibits Cryptococcus neoformans In Vitro and In Vivo by Targeting the Prp8 Intein Splicing.

Authors:  Anil Mathew Tharappel; Zhong Li; Yan Chun Zhu; Xiangmeng Wu; Sudha Chaturvedi; Qing-Yu Zhang; Hongmin Li
Journal:  ACS Infect Dis       Date:  2022-08-10       Impact factor: 5.578

2.  EUCAST-Obtained Olorofim MICs against Aspergillus and Scedosporium Species and Lomentospora prolificans Showed High Agreements between Visual Inspection and Spectrophotometric Readings.

Authors:  Pilar Escribano; Ana Gómez; Elena Reigadas; Patricia Muñoz; Jesús Guinea
Journal:  Antimicrob Agents Chemother       Date:  2022-08-04       Impact factor: 5.938

3.  In Vitro Activity of Amphotericin B in Combination with Colistin against Fungi Responsible for Invasive Infections.

Authors:  Patrick Schwarz; Ilya Nikolskiy; Anne-Laure Bidaud; Frank Sommer; Gert Bange; Eric Dannaoui
Journal:  J Fungi (Basel)       Date:  2022-01-26

Review 4.  Updated EUCAST Clinical Breakpoints against Aspergillus, Implications for the Clinical Microbiology Laboratory.

Authors:  Jesús Guinea
Journal:  J Fungi (Basel)       Date:  2020-12-06

5.  Azole-Resistant Aspergillus fumigatus Clinical Isolate Screening in Azole-Containing Agar Plates (EUCAST E.Def 10.1): Low Impact of Plastic Trays Used and Poor Performance in Cryptic Species.

Authors:  Julia Serrano-Lobo; Ana Gómez; Belén Rodríguez-Sánchez; Patricia Muñoz; Pilar Escribano; Jesús Guinea
Journal:  Antimicrob Agents Chemother       Date:  2021-07-16       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.